Results 251 to 260 of about 64,386 (306)

Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers. [PDF]

Res Pract Thromb Haemost
Kumar R, Drake E, Stanek J, Yeager N, Vrooman LM, Silverman LB, Rodriguez V.   +6 more
europepmc   +1 more source

Extended thromboprophylaxis after hip fracture surgery: Real-world evidence of direct oral anticoagulants versus low molecular weight heparin of unfractionated heparin. [PDF]

PLoS One
Clavijo MM, Ruiz JI, Brindicci MR, Rodriguez P, Wauters V, Reparaz MLAV, Mountford A, Monteagudo M, Camarero M, Casali CE, Mahuad C, Aizpurua F, Zerga ME, Ventura A, Siciliano N, Garate G.   +15 more
europepmc   +1 more source

Direct oral anticoagulants measurement: when is it necessary? [PDF]

Blood Transfus
Tripodi A, Marchetti M, Scalambrino E.
europepmc   +1 more source

Comparison of treatment outcomes of direct oral anticoagulants and heparin for patients with Takotsubo cardiomyopathy: A nationwide cohort analysis. [PDF]

PLoS One
Hijikata S, Inoue N, Fushimi K, Sasano T.   +3 more
europepmc   +1 more source

Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trial. [PDF]

Eur Stroke J
Polymeris AA, Rossel JB, Koga M, Strbian D, Vedamurthy A, Krishnan M, Branca M, Meinel T, Kristoffersen ES, Yoshimoto T, Tanaka K, Kunieda T, Yakushiji Y, Vehoff J, Matsuzono K, Slade P, Demeestere J, Salerno A, Caracciolo NG, Hemelsoet D, Engelter ST, Auer E, Horvath T, Seiffge DJ, Goeldlin M, Dawson J, Fischer U.   +26 more
europepmc   +1 more source

Comparing the Direct Oral Anticoagulants versus Vitamin K Antagonists in Bioprosthetic Valves: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Clin Appl Thromb Hemost
Waseem MH, Abideen ZU, Cheema AH, Farhan K, Raja HAA, Tahir MZ, Saleem F, Nadeem A, Thada PK.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Direct Oral Anticoagulants

DeckerMed Critical Care of the Surgical Patient, 2017
Non–vitamin K antagonist oral anticoagulants, also known as direct oral anticoagulants, are a relatively recent class of medications introduced into clinical practice. Due to their safety profiles, fixed dosing, and lack of need for frequent laboratory monitoring, they are becoming preferred to traditional anticoagulation with warfarin in many cases of
Michael G Mount, Panna A. Codner
openaire   +2 more sources

Measuring Direct Oral Anticoagulants

2017
Direct oral anticoagulants (DOACs) can be quantified using methods that can be performed in any clinical or research laboratory using manual or automated instrument platforms. Dabigatran etexilate, the oral direct thrombin inhibitor, can be quantified by drug-calibrated clot or chromogenic-based assays using either thrombin or ecarin as substrates ...
Robert C, Gosselin, Jonathan, Douxfils
openaire   +3 more sources

New anticoagulants: Moving beyond the direct oral anticoagulants

Journal of Thrombosis and Haemostasis, 2021
Although anticoagulants have been in use for more than 80 years, heparin and vitamin K antagonists were the sole available options until recently. Although these agents revolutionized the prevention and treatment of thrombotic diseases, their use has been hampered by the necessity for coagulation monitoring and by bleeding complications resulting in ...
James C. Fredenburgh, Jeffrey I. Weitz
openaire   +2 more sources